Inventor · disambiguated record
Tetsuya Yamagata
Also filed as: YAMAGATA TETSUYA
9 granted patents·5 pending applications·205 citations·filing 1977–2022
85Inventor score
Top patents by PatentIndex Score
14 records- 0189US4393076AAnti-inflammatory and analgesic gel compositionHISAMITSU PHARMACEUTICAL CO·Filed 1982·Granted Jul 12, 1983·84 cites·15 claims
- 0287US4455146ANovel plastersHISAMITSU PHARMACEUTICAL CO·Filed 1982·Granted Jun 19, 1984·65 cites·11 claims
- 0386US4205685AThermogenic sheet-combined poulticesHISAMITSU PHARMACEUTICAL CO·Filed 1977·Granted Jun 3, 1980·56 cites·10 claims
- 0471US12152259B2Modified CAS9 protein, and use thereofUNIV TOKYO·Filed 2022·Granted Nov 26, 2024·0 cites·15 claims
- 0558US11530396B2Modified CAS9 protein, and use thereofUNIV TOKYO·Filed 2018·Granted Dec 20, 2022·0 cites·25 claims
- 0658US11473071B2Method for treating muscular dystrophy by targeting utrophin geneASTELLAS PHARMA INC·Filed 2021·Granted Oct 18, 2022·0 cites·17 claims
- 0751US2023323456A1Method for treating facioscapulohumeral muscular dystrophy (fshd) by targeting dux4 geneMODALIS THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 0850US12502418B2Method for treating muscular dystrophy by targeting LAMA1 geneMODALIS THERAPEUTICS CORP·Filed 2020·Granted Dec 23, 2025·0 cites·13 claims
- 0944US2022233721A1Method for treating muscular dystrophy by targeting dmpk geneASTELLAS PHARMA INC·Filed 2020·Application pending·0 cites
- 1043US11439692B2Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM systemMODALIS THERAPEUTICS CORP·Filed 2018·Granted Sep 13, 2022·0 cites·17 claims
- 1143US2023248810A1Method for treating alzheimer's disease by targeting mapt geneMODALIS THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 1241US2021332094A1Novel transcription activatorMODALIS THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 1340US11591621B2Method of treating diseases associated with elevated KRAS expression using CRISPR-GNDM systemMODALIS THERAPEUTICS CORP·Filed 2018·Granted Feb 28, 2023·0 cites·8 claims
- 1440US2022017881A1MODIFIED Cas9 PROTEIN AND USE THEREOFMODALIS THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tetsuya Yamagata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →